These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34688945)

  • 1. Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
    Amarsy R; Trystram D; Cambau E; Monteil C; Fournier S; Oliary J; Junot H; Sabatier P; Porcher R; Robert J; Jarlier V;
    Int J Infect Dis; 2022 Jan; 114():90-96. PubMed ID: 34688945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of the first year of the COVID-19 pandemic on the epidemiology of invasive infections (bacteremia) in the hospitals of the Assistance Publique-Hôpitaux de Paris].
    Amarsy R; Robert J; Jarlier V
    Bull Acad Natl Med; 2023 Feb; 207(2):131-135. PubMed ID: 36532694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.
    Sinto R; Lie KC; Setiati S; Suwarto S; Nelwan EJ; Djumaryo DH; Karyanti MR; Prayitno A; Sumariyono S; Moore CE; Hamers RL; Day NPJ; Limmathurotsakul D
    Antimicrob Resist Infect Control; 2022 May; 11(1):73. PubMed ID: 35590391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study.
    Anderson DJ; Moehring RW; Sloane R; Schmader KE; Weber DJ; Fowler VG; Smathers E; Sexton DJ
    PLoS One; 2014; 9(3):e91713. PubMed ID: 24643200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections and antimicrobial resistance of responsible pathogens in Ukraine: results of a multicenter study (2013-2015).
    Salmanov AG; Voronenko YV; Vozianov SO; Shunko YY; Mamenko MY; Verner OM; Mykhalchuk VM; Vydyborets SV; Shkorbotun VO; Beketova HV; Okhotnikova OM; Goryainova NV; Oshlianska OA; Laksha O; Bielova O; Shuba VY; Osadcha TM
    Wiad Lek; 2019; 72(11 cz 1):2069-2075. PubMed ID: 31860848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
    Bauer KA; Puzniak LA; Yu KC; Finelli L; Moise P; Ai C; Watts JA; Gupta V
    BMC Infect Dis; 2022 Nov; 22(1):841. PubMed ID: 36368931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early deaths in bloodstream infections: a population-based case series.
    Kontula KS; Skogberg K; Ollgren J; Järvinen A; Lyytikäinen O
    Infect Dis (Lond); 2016; 48(5):379-85. PubMed ID: 26763410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
    Tian L; Sun Z; Zhang Z
    BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 pandemic on hospital onset bloodstream infections (HOBSI) at a large health system.
    Sturm LK; Saake K; Roberts PB; Masoudi FA; Fakih MG
    Am J Infect Control; 2022 Mar; 50(3):245-249. PubMed ID: 34971717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study.
    Segala FV; Pafundi PC; Masciocchi C; Fiori B; Taddei E; Antenucci L; De Angelis G; Guerriero S; Pastorino R; Damiani A; Posteraro B; Sanguinetti M; De Pascale G; Fantoni M; Murri R
    Infection; 2023 Aug; 51(4):1061-1069. PubMed ID: 36867310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study.
    Palanisamy N; Vihari N; Meena DS; Kumar D; Midha N; Tak V; Sharma A; Bohra GK; Kothari N; Dutt N; Bhatia PK; Garg MK; Misra S
    BMC Infect Dis; 2021 Sep; 21(1):933. PubMed ID: 34496787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study.
    Tsai YH; Hou TC; Liu PY; Chen CJ; Wang JM
    In Vivo; 2024; 38(4):1965-1972. PubMed ID: 38936952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
    Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
    J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Escherichia coli bloodstream infection antimicrobial resistance trends across South West England during the first 2 years of the coronavirus disease 2019 pandemic response.
    Stanley J; Sullivan B; Dowsey AW; Jones K; Beck CR
    Clin Microbiol Infect; 2024 Oct; 30(10):1291-1297. PubMed ID: 38527612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care-Associated Infections in Australia: A Retrospective Case-cohort Study.
    Lee XJ; Stewardson AJ; Worth LJ; Graves N; Wozniak TM
    Clin Infect Dis; 2021 May; 72(10):e506-e514. PubMed ID: 32822465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control.
    Pérez-Granda MJ; Carrillo CS; Rabadán PM; Valerio M; Olmedo M; Muñoz P; Bouza E
    J Hosp Infect; 2022 Jan; 119():149-154. PubMed ID: 34627934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.